Biogen Inc. (BIIB) NASDAQ
183.05
+2.3804(+1.32%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
183.05
+2.3804(+1.32%)
Currency In USD
| Market Cap | 25.82B |
| Enterprise Value | 29.76B |
| P/E Ratio | 20.76 |
| PEG Ratio | -0.98 |
| Price/Sales Ratio | 2.74 |
| Price/Book Ratio | 1.47 |
| Enterprise/Revenue | 3.14 |
| Enterprise/EBITDA | 9.93 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.13 |
| Operating Margin | 0.19 |
| Return On Assets | 0.04 |
| Return On Equity | 0.07 |
| Revenue | 9.81B |
| Revenue/Share | 66.88 |
| Gross Profit | 6.91B |
| EBITDA | 3.1B |
| Net Income | 1.29B |
| Diluted EPS | 8.83 |
| Total Cash | 3.82B |
| Total Cash/Share | 26.01 |
| Total Debt | 6.95B |
| Total Debt/Equity | 0.38 |
| Current Ratio | 2.68 |
| Book Value Per Share | 124.45 |
| 52-Week Change | 53.67 |
| 52-Week High | 202.41 |
| 52-Week Low | 115.25 |
| Moving Average 50 Days | 185.2 |
| Moving Average 200 Days | 163.29 |
| Average Volume | 1.24M |
| Shares Outstanding | 146.76M |
| % Held by Institutions | 95.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
| Last Split Date | January 18, 2001 |